Riluzole in Huntington's disease (HD): An open label study with one year follow up

Journal of Neurology

Volumn 248, Issue 10, 2001, Pages 866-869

  Seppi, Klaus ^a   Mueller, Joerg ^a   Bodner, Thomas ^a   Brandauer, Elisabeth ^a   Benke, Thomas ^a   Weirich Schwaiger, Helga ^b   Poewe, Werner ^a   Wenning, Gregor K ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Huntington's disease; Open label; Riluzole; Unified HD rating scale

Indexed keywords

FLUNITRAZEPAM; HALOPERIDOL; LIVER ENZYME; MIANSERIN; RILUZOLE; SULPIRIDE; TIAPRIDE; ZOLPIDEM;

ADULT; AGED; ARTICLE; CHOREA; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; ENZYME BLOOD LEVEL; EVALUATION; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; MOTOR DYSFUNCTION; NEUROPROTECTION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RATING SCALE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PSYCHOMOTOR PERFORMANCE; RILUZOLE;

EID: 0034796483     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150170071     Document Type: Article

References (10)

1. A controlled trial of riluzole in amyotrophic lateral sclerosis
2. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
3. Assessment of coenzyme Q10 tolerability in Huntington's disease
4. Unified Huntington's Disease Rating Scale: Reliability and consistency
5. A controlled trial of remacemide hydrochloride in Huntington's disease
6. Dose-ranging study of riluzole in amyotrophic lateral sclerosis
7. Riluzole therapy in Huntington's disease (HD)
8. Huntington disease: Clinical care and evaluation
9. A controlled clinical trial of baclofen as protective therapy in early Huntington's disease
10. Unified Huntington's disease rating scale: A follow up